TERT-BUTYL 4-OXO-1-OXA-8-AZASPIRO[4.5]DECANE-8-CARBOXYLATE, 95.0%, 5g

2-Bromo-N-(4-methylphenyl)propanamide, 95.0%, 1g

1-(2,4-Difluorophenyl)-N-methylmethanamine, 95.0%, 25g

Formic acid, min. 98%, for synthesis, 10 l, plastic packaging.

(R)-3-Methyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butan-1-amine hydrochloride, 95.0%, 10g

4,5-Dimethoxy-isatoic anhydride, 95.0%, 5g

2-Cyanoethyl Acrylate (stabilized with MEHQ)>95.0%(GC)5g

N-cyclohexyl-1-methylpiperidin-4-amine, 85.0%, 5g

4-BENZYL-2-(IODOMETHYL)-2,6,6-TRIMETHYLMORPHOLINE, 95.0%, 1g

methyl 3-cyclopropyl-1-methyl-1H-pyrazole-5-carboxylate, 250mg

5-Hydroxyisoquinoline, 95.0%, 5g

tert-Butyl 4-(hydroxyimino)piperidine-1-carboxylate, 95.0%, 1g

3-(2-Pyridyl)-5,6-diphenyl-1,2,4-triazine, 98.0%, 25g